| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |